Naimish Patel
Chief Medical Officer at CRISPR Therapeutics AG (CRSP)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-6.0%
vs. S&P 500-9.1%
Beat the market0%
Paper profit on buys+$31K
Total bought / sold$50K / $363K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 1SEC | CRSPCRISPR Therapeutics AG | Sell | 3,78619,357 held (−16%) | $55.62 | $211K | -4.0% |
| Mar 17SEC | CRSPCRISPR Therapeutics AG | Sell | 3,15013,143 held (−19%) | $48.26 | $152K | +10.6% |
| Jan 27SEC | CRSPCRISPR Therapeutics AG | Buy | 1,508new position | $32.96 | $50K | +62.0% |
- Buy
Chief Medical Officer Naimish Patel bought $50K of CRSP at $32.96 — first open-market purchase in our records; opens a new position.